Discover 3 European Penny Stocks With Market Caps Under €90M

Mon, Aug 11, 2025, 7:05 AM 4 min read

The European stock market has recently experienced a positive shift, with the pan-European STOXX Europe 600 Index rising by 2.11% amid strong corporate earnings and optimism surrounding geopolitical developments. For investors exploring beyond traditional large-cap stocks, penny stocks—often smaller or newer companies—can present intriguing opportunities. Although the term may seem outdated, these stocks are still relevant today as they offer potential growth at lower price points while maintaining financial resilience and solid fundamentals.

Click here to see the full list of 341 stocks from our European Penny Stocks screener.

We’re going to check out a few of the best picks from our screener tool.

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Cellularline S.p.A. manufactures and sells smartphone and tablet accessories across various regions including Europe, the Middle East, North America, and internationally, with a market cap of €63.49 million.

Operations: The company generates revenue primarily from its Electronic Components & Parts segment, amounting to €164.26 million.

Market Cap: €63.49M

Cellularline S.p.A. shows potential as a penny stock with its stable weekly volatility and experienced management team. The company’s earnings grew by 57.1% last year, outpacing the tech industry, though it has faced a decline over five years. It trades at a significant discount to its estimated fair value and has high-quality earnings with well-covered debt levels by operating cash flow. Short-term assets cover both short- and long-term liabilities comfortably, but the dividend track record is unstable. Recent share repurchase announcements aim to support market liquidity and enhance shareholder value through strategic buybacks of up to €3.8 million worth of shares.

• Get an in-depth perspective on Cellularline’s performance by reading our balance sheet health report here.

• Evaluate Cellularline’s prospects by accessing our earnings growth report.

Simply Wall St Financial Health Rating: ★★★★★☆